The fusion protein led to the expansion of CD8+ tumor infiltrating lymphocytes (TILs) with a less exhausted phenotype, expressing lower levels of PD-1 and TOX and higher levels of TCF-1. This evidence concerns the gene CD8A and neoplasm.